Leukemia Clinical Trials in North Carolina

Showing 721-740 of 1,513 trials

High Dose Vitamin A Compound in Treating Participants With Resectable Non-Small Cell Lung Cancer

NCT03870529

This trial studies how well high dose vitamin A compound works in treating participants with non-small cell lung cancer that can be removed by surgery. Vitamin A compound may increase the number of germinal centers (immune centers that make antibodies mature) in tumor and lymph tissues which may be beneficial to patients with cancer.

Non Small Cell Lung CancerStage I Lung CancerStage Ib Lung Carcinoma+3 more

Wake Forest University Health Sciences20 participantsStarted Aug 2019

Winston-Salem, North Carolina, United States

COMPLETEDPhase 257 miles

Sorafenib Tosylate in Treating Patients With Metastatic, Locally Advanced, or Recurrent Medullary Thyroid Cancer

NCT00390325

This phase II trial studies how well sorafenib tosylate works in treating patients with medullary thyroid cancer that has spread to other parts of the body (metastatic), spread to the tissue surrounding the thyroid (locally advanced), or has returned after a period of improvement (recurrent). Sorafenib tosylate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor.

Hereditary Thyroid Gland Medullary CarcinomaLocally Advanced Thyroid Gland Medullary CarcinomaMultiple Endocrine Neoplasia Type 2A+8 more

National Cancer Institute (NCI)21 participantsStarted Nov 2006

St Louis, Missouri, United States • Durham, North Carolina, United States • Columbus, Ohio, United States

High Dose Vitamin A Compound in Treating Participants With Resectable Non-Small Cell Lung Cancer

Sorafenib Tosylate in Treating Patients With Metastatic, Locally Advanced, or Recurrent Medullary Thyroid Cancer

Leukemia Trials in Other Cities

A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms

A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies

CYC065 CDK Inhibitor and Venetoclax Study in Relapsed/Refractory CLL

Lorlatinib in Combination With Chemotherapy in Participants With Metastatic Anaplastic Lymphoma Kinase Positive (ALK+) Non-small Cell Lung Cancer (NSCLC) Who Progressed on Single-agent Lorlatinib

Prospective Clinicogenomic Program

A Study of PRT2527 in Participants With Advanced Solid Tumors

OSE2101 Versus Chemotherapy in HLA-A2 Positive Patients With Advanced NSCLC After Immune Checkpoint Inhibitor Failure

EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)

A Study for Oral SY-2101 for Participants With Acute Promyelocytic Leukemia

CD40 Agonistic Antibody APX005M (Sotigalimab) in Combination With Nivolumab

A Study of CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers

A Clinical Trial of Durvalumab (MEDI4736) as 1st Line Therapy in Advanced Non-small Cell Lung Cancer Patients

Antigen-specific T Cell Therapy for AML or MDS Patients With Relapsed Disease After Allo-HCT

A Clinical Study Evaluating Nivolumab-containing Treatments in Patients With Advanced Non-small Cell Lung Cancer After Failing Previous PD-1/(L)1 Therapy and Chemotherapy

Study Investigating NTLA-5001 in Subjects With Acute Myeloid Leukemia

A Study of Olaparib Prior to Surgery and Chemotherapy in Ovarian, Primary Peritoneal, and Fallopian Tube Cancer

Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies

Survival Prolongation by Rationale Innovative Genomics

Other Conditions in North Carolina